Phase II Randomized Trial Comparing PLA to HIGRT Therapy (PROVE-HCC)
Condition: Hepatocellular Carcinoma Interventions: Procedure: Percutaneous Local Abalation; Radiation: Hypofractionated Image Guided Radaition Therapy Sponsors: Duke University; Durham VA Medical Center Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials